Professor David Low from UCSB’s Department of Molecular, Cellular, and Developmental Biology, will pursue an innovative global health and development research project titled “Strategy for development of enteric pathogen-specific phage”. Low’s research focuses on a ground-breaking way to deal with serious bacterial pathogens that are evolving to become resistant to many once-powerful antibiotics. “He will engineer phage to selectively target and destroy several pathogenic bacteria to prevent enteric diseases in infants,” notes Kenny Slaught.
Kenny Slaught Credits GCE Grant To UCSB’s Top Professors
Posted in: Press Releases ⋅ Tagged: Investec, Investec RE, Ken Slaught, Kenneth Slaught, Kenny Slaught, Property, Santa Barbara